pharma · Metachromatic Leukodystrophy (MLD) · Late Metachromatic Leukodystrophy (MLD)
Shire
Shire trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
JP HQ
3,523 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- JP
- Employees
- 3,523
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Shire clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Shire programs — each row shows trial ID, program name, phase, status, and indication.
Shire trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Shire.
-
Recombinant human arylsulfatase A — Phase 2
Clinical update -
Elaprase for intravenous (IV) infusion — Approved
Clinical update -
SHP611 — Phase 2
Clinical update -
rhASA — Phase 2
Clinical update -
rhASA — Phase 2
Clinical update -
Maribavir — Phase 3
Clinical update -
Ontamalimab — Phase 3
Clinical update -
SHP615 — Phase 3
Clinical update